Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells

Thrombosis Research

Volumn 97, Issue 5, 2000, Pages 343-347

  Ohta, Shoichiro ^a   Niiya, Kenji ^b   Sakuragawa, Nobuo ^a   Fuse, Hideki ^a  

^a Faculty of Medicine   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Lipopolysaccharide; PC 3; Urokinase type plasminogen activator

Indexed keywords

CYCLOHEXIMIDE; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; UROKINASE;

ARTICLE; BONE METASTASIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR GROWTH;

ANIMALS; BLOTTING, NORTHERN; ENZYME INDUCTION; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033972501     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00174-7     Document Type: Article

References (16)

1. Persky B., Ostrowski L.E., Pagast P., Ahsan A., Schultz R.M. Inhibition of proteolytic enzymes in an in vitro amnion model for basement membrane invasion. Cancer Res. 46:1986;4129-4134.
2. Dano K., Anderson P.A., Grondahl-Hansen J., Kristensen P., Nielson L.S., Skriver L. Plasminogen activators, tissue degeneration, and cancer. Adv Cancer Res. 44:1985;139-266.
3. Boyd D., Florent G., Kim P., Brattain M. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res. 48:1988;3112-3116.
4. de Bruin P.A., Griffioen G., Verspaget H.W., Verheiken J.H., Lamers C.B. Plasminogen activators and tumor development in the human colon. Activity levels in normal mucosa, adenomatous polyp, and adenocarcinomas Cancer Res. 47:1987;4654-4657.
5. Kirchheimer J.C., Huber K., Wagner O., Bincer B.R. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas. Br J Haematol. 66:1987;85-89.
6. Duffy M.J., O'Grady P., Devaney D., O'Siorain Fennelly J.J., Lijnen H.J. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report. Cancer. 62:1988;531-533.
7. Wun T.C., Schleuning W.D., Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem. 257:1982;3276-3283.
8. Niiya K., Nsimba M., Hayashi T., Sakuragawa N. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors. Thromb Res. 65:1992;311-321.
9. Jones E.G., Goddard L., Harper M.E. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostatic tissue. Human Pathol. 27:1996;688-694.
10. Niiya K., Shinbo M., Ozawa T., Hayakawa Y., Sakuragawa N. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb Haemost. 74:1995;1511-1515.
11. Wojta J., Zoellner H., Gallicchio M., Filonzi E.L., Hamillton J.A., McGrath K. Interferon-alpha2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro. Lymphokine Cytokine Res. 13:1994;133-138.
12. Marshall B.C., Xu Q.P., Rao N.V. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J Biol Chem. 267:1992;11462-11469.
13. Busso N., Nicodeme E., Chesne C., Guillouzo A., Belin D., Hyafil F. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes. modulation by inflammatory agents Hepatology. 20:1994;186-190.
14. Tsukada J., Saito K., Waterman W.R., Webb A.C., Auron P.E. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol Cell Biol. 14:1994;7285-7297.
15. Godambe S.A., Chaplin D.D., Takova T., Bellone C.J. Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of murine interleukin-1 beta gene. J Immunol. 153:1994;143-152.
16. Wernert N., Gilles F., Fafeur V., Bouali F., Raes M.B., Pyke C., Dupressoir T., Seitz G., Vandenbunder B., Stehelin D. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res. 54:1994;5683-5688.